Viewing Study NCT02159495

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2026-02-24 @ 5:50 AM
Study NCT ID: NCT02159495
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-16
First Post: 2014-06-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
Sponsor: City of Hope Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Acute Myeloid Leukemia in Remission View
None Acute Biphenotypic Leukemia View
None Early Relapse of Acute Myeloid Leukemia View
None Late Relapse of Acute Myeloid Leukemia View
None Recurrent Adult Acute Myeloid Leukemia View
None Secondary Acute Myeloid Leukemia View
None Blastic Plasmacytoid Dendritic Cell Neoplasm View
None Acute Myeloid Leukemia View
None Adult Acute Lymphoblastic Leukemia View
None Interleukin-3 Receptor Subunit Alpha Positive View
None Minimal Residual Disease View
None Refractory Acute Myeloid Leukemia View
None Untreated Adult Acute Myeloid Leukemia View
Keywords: